Powered by
Freenome
Why join Freenome?
Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.
Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning.
Founded in 2014, Freenome has ~400 employees and continues to grow to match the scope of our ambitions to provide access to better screening and earlier cancer detection.
At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.
Become a Freenomer
Do you have what it takes to be a Freenomer? A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.
About this opportunity:
At Freenome, we are seeking a Senior Staff Scientist to help grow the Freenome Genomics Early Development team. The ideal candidate will serve as an expert in the field and a technical assay architect to lead end-to-end development and optimization of new and existing Genomics targeted/NGS assay workflows and processes that are ready for scale-up, automation and implementation in a clinical laboratory. You will collaborate extensively with the Molecular Research, Computational Science, Late Development, Manufacturing, Quality, Regulatory & Program Management teams to develop and transfer technologies into a regulated, high-throughput environment and contribute to Freenome’s multiomic product portfolio aimed at early cancer detection. You will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
The role reports to the Senior Director, Development. This role will be an on-site role based in our Brisbane, California headquarters.
What you’ll do:
Must haves:
Nice to haves:
Benefits and additional information:
The US target range of our base salary for new hires is $166,175 - $252,500. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
#LI-Onsite
